GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
Material
Language
Subjects(RVK)
  • 1
    In: JAMA Network Open, American Medical Association (AMA), Vol. 4, No. 11 ( 2021-11-05), p. e2132376-
    Type of Medium: Online Resource
    ISSN: 2574-3805
    Language: English
    Publisher: American Medical Association (AMA)
    Publication Date: 2021
    detail.hit.zdb_id: 2931249-8
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Blood, American Society of Hematology, Vol. 120, No. 21 ( 2012-11-16), p. 1294-1294
    Abstract: Abstract 1294 Conditional inactivation of both the essential non-homologous DNA end-joining repair gene XRCC4 and the tumor suppressor gene p53 in mature B cells in mice frequently leads to mature B cell lymphomas. The majority of B lymphomas recurrently harbor reciprocal IgH/c-Myc translocations, activating c-Myc, a hallmark characteristic of Burkitt's lymphoma. We designed an integrated tumor RNA-Seq transcriptome profiling and miRnome based approach to dissect the interplay of signaling pathways and oncogenic signatures that lead to the development of the tumors in our model. Differential expression analysis of mRNA and 709 miRNAs reveal specific alterations in distinct signaling pathways, including upregulation of both Wnt and PI3K pathway signaling. For example, we found that Wnt10b, the wnt ligand expressed in B cells is upregulated. Correspondingly, frizzled receptors and it's downstream effector disheveled are also upregulated, factors that contribute to beta-catenin stabilization. Our studies also reveal increased expression PIK3CD, a PI3K catalytic isoform expressed in B cells, with corresponding downregulation of miRNAs with seed matches to 3'UTR of PIK3CD in the tumor; a factor that likely contribute to the stabilization of PIK3CD mRNA. Our analyses reveal an interplay of multiple pathway proteins and genes that serve as novel therapeutic targets for human B lymphoma. Disclosures: No relevant conflicts of interest to declare.
    Type of Medium: Online Resource
    ISSN: 0006-4971 , 1528-0020
    RVK:
    RVK:
    Language: English
    Publisher: American Society of Hematology
    Publication Date: 2012
    detail.hit.zdb_id: 1468538-3
    detail.hit.zdb_id: 80069-7
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    American Society of Hematology ; 2011
    In:  Blood Vol. 118, No. 21 ( 2011-11-18), p. 5238-5238
    In: Blood, American Society of Hematology, Vol. 118, No. 21 ( 2011-11-18), p. 5238-5238
    Abstract: Abstract 5238 The requirement for Myc oncogenes in cellular transformation and tumor progression in human cancers has been studied extensively. Others and we have shown that the spontaneous development and progression of B lymphomas involving translocations that activate c-Myc can be faithfully recapitulated in model systems. However, for other oncogenes that are the predominant translocation targets in hematopoietic malignancies in humans, such as Bcl6, animal models that spontaneously promote translocations involving them are still lacking. Importantly, the molecular basis for the recurrence of particular oncogene translocations remains undefined. We have shown that a breakdown in DNA double strand break (DSB) repair resulting from conditionally inactivating the essential non-homologous end-joining (NHEJ) repair gene XRCC4 in p53 (XcP) deficient mature B cells reproducibly leads to the development of mature B lymphomas. These lymphomas, termed CD21/XcP, routinely harbor a clonal translocation that fuses IgH switch (S) regions to exon 1 of c-Myc, which we showed are formed by the aberrant repair of AID-induced DSBs during IgH Class Switch Recombination (CSR). These lymphomas harbor also a second clonal translocation that fuses the Igl locus into various chromosomal locations, including c-Myc, which our studies showed were formed by aberrant V(D)J recombination. Juxtaposition of Ig heavy chain (IgH) sequences to the c-Myc oncogene is one of the most extensively modeled and well-studied translocations. It is a hallmark of Burkitts Lymphoma, a subset of other B lymphomas. By limiting or eliminating c-Myc via conditional c-Myc inactivation in peripheral naïve and GC B cells in wildtype, p53 deficient and combined XRCC4 and p53 deficient settings, our studies reveal new insights into normal, functional requirements for C-myc in peripheral B lymphocytes, selection mechanisms underlying its activation in B lymphomagenesis, and the identification of new oncogenic translocation partners resulting from its inactivation in the CD21/XcP model. Disclosures: No relevant conflicts of interest to declare.
    Type of Medium: Online Resource
    ISSN: 0006-4971 , 1528-0020
    RVK:
    RVK:
    Language: English
    Publisher: American Society of Hematology
    Publication Date: 2011
    detail.hit.zdb_id: 1468538-3
    detail.hit.zdb_id: 80069-7
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: Nature, Springer Science and Business Media LLC, Vol. 460, No. 7252 ( 2009-7), p. 231-236
    Type of Medium: Online Resource
    ISSN: 0028-0836 , 1476-4687
    RVK:
    RVK:
    RVK:
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2009
    detail.hit.zdb_id: 120714-3
    detail.hit.zdb_id: 1413423-8
    SSG: 11
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    In: Nature, Springer Science and Business Media LLC, Vol. 449, No. 7161 ( 2007-9), p. 478-482
    Type of Medium: Online Resource
    ISSN: 0028-0836 , 1476-4687
    RVK:
    RVK:
    RVK:
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2007
    detail.hit.zdb_id: 120714-3
    detail.hit.zdb_id: 1413423-8
    SSG: 11
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    Ovid Technologies (Wolters Kluwer Health) ; 2017
    In:  Journal of Clinical Gastroenterology Vol. 51, No. 4 ( 2017-04), p. 378-383
    In: Journal of Clinical Gastroenterology, Ovid Technologies (Wolters Kluwer Health), Vol. 51, No. 4 ( 2017-04), p. 378-383
    Abstract: To evaluate age-specific disparities in cancer stage at diagnosis, receipt of treatment, and survival among adults with hepatocellular carcinoma (HCC). Background: HCC has become the fastest rising cause of cancer-related deaths in the United States. The aging population coupled with the rising incidence of HCC will result in an emerging cohort of older patients with HCC placing significant burden health care systems. Study: Using 2003 to 2011 Surveillance, Epidemiology, and End Results data, a US population-based cancer registry, we retrospectively evaluated age-specific disparities in cancer stage at diagnosis, receipt of treatment, and survival among adults with HCC. Multivariate logistic regression models evaluated HCC stage at diagnosis and HCC treatment received. Multivariate Cox proportional hazard models evaluated long-term survival. Results: Compared with HCC patients below 50 years old, patients aged 70 years or older were less likely to have HCC within Milan criteria [odds ratio, 0.58; confidence interval (CI), 0.54-0.63; P 〈 0.001]. Older age was also associated with significantly lower rates of receiving HCC treatment. Even after adjusting for stage of disease, patients aged 70 years or older had the lowest odds of receiving any HCC treatment compared with patients below 50 years old (odds ratio, 0.52; CI, 0.46-0.60; P 〈 0.001). On multivariate Cox regression, HCC patients aged 70 years or older had significantly lower survival compared with patients below 50 years old (hazards ratio, 1.22; CI, 1.15-1.30; P 〈 0.001). Conclusions: Among US adults with HCC, patients aged 70 years or older were less likely to have HCC within Milan criteria at diagnosis, less likely to receive any HCC treatment, and had significantly lower long-term survival.
    Type of Medium: Online Resource
    ISSN: 0192-0790
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2017
    detail.hit.zdb_id: 2041558-8
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    Online Resource
    Online Resource
    Springer Science and Business Media LLC ; 2009
    In:  Nature Vol. 462, No. 7274 ( 2009-12), p. 803-807
    In: Nature, Springer Science and Business Media LLC, Vol. 462, No. 7274 ( 2009-12), p. 803-807
    Type of Medium: Online Resource
    ISSN: 0028-0836 , 1476-4687
    RVK:
    RVK:
    RVK:
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2009
    detail.hit.zdb_id: 120714-3
    detail.hit.zdb_id: 1413423-8
    SSG: 11
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    In: Proceedings of the National Academy of Sciences, Proceedings of the National Academy of Sciences, Vol. 107, No. 7 ( 2010-02-16), p. 3024-3029
    Abstract: DNA ligase IV (LIG4) is an essential component of the nonhomologous end-joining (NHEJ) repair pathway and plays a key role in V(D)J recombination. Hypomorphic LIG4 mutations in humans are associated with increased cellular radiosensitivity, microcephaly, facial dysmorphisms, growth retardation, developmental delay, and a variable degree of immunodeficiency. We have generated a knock-in mouse model with a homozygous Lig4 R278H mutation that corresponds to the first LIG4 mutation reported in humans. The phenotype of homozygous mutant mice Lig4 R278H/R278H ( Lig4 R/R ) includes growth retardation, a decreased life span, a severe cellular sensitivity to ionizing radiation, and a very severe, but incomplete block in T and B cell development. Peripheral T lymphocytes show an activated and anergic phenotype, reduced viability, and a restricted repertoire, reminiscent of human leaky SCID. Genomic instability is associated with a high rate of thymic tumor development. Finally, Lig4 R/R mice spontaneously produce low-affinity antibodies that include autoreactive specificities, but are unable to mount high-affinity antibody responses. These findings highlight the importance of LIG4 in lymphocyte development and function, and in genomic stability maintenance, and provide a model for the complex phenotype of LIG4 syndrome in humans.
    Type of Medium: Online Resource
    ISSN: 0027-8424 , 1091-6490
    RVK:
    RVK:
    Language: English
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date: 2010
    detail.hit.zdb_id: 209104-5
    detail.hit.zdb_id: 1461794-8
    SSG: 11
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    Online Resource
    Online Resource
    American Society of Hematology ; 2012
    In:  Blood Vol. 120, No. 21 ( 2012-11-16), p. 2328-2328
    In: Blood, American Society of Hematology, Vol. 120, No. 21 ( 2012-11-16), p. 2328-2328
    Abstract: Abstract 2328 Increased DNA damage is the principal factor that contributes to the functional decline in hematopoietic stem cell (HSC) renewal and in the immune system during ageing. Non-homologous DNA end-joining (NHEJ) is a major pathway that repairs DNA double strand breaks (DSBs) in mammalian cells. NHEJ is critical for the repair of DSBs generated by V(D)J recombination (VDJ) and IgH class switch recombination (CSR), and general DSBs in all cell types, including those that suppress the capacity of HSCs to self-renew during ageing. In recent studies, NHEJ is implicated in the repair of DNA damage in quiescent long-lived HSCs in ex-vivo cell-based assays. However, whether NHEJ might play a physiological role in the repair of DNA damage required for maintaining HSC homeostasis remains unclear. DNA Ligase IV (Lig4) which catalyzes the end-ligation of broken DNA ends mediated by NHEJ, is absolutely required for VDJ and CSR, and has no known functions outside of NHEJ. Because a deficiency in Lig4 in mice is embryonic lethal, and there are no known human Lig4-null alleles, here we assess whether Lig4 plays a physiological role in HSC homeostasis by assaying HSC functions in a knock-in mouse model of the human recessive hypomorphic R278H mutation in Lig4 which underlies the rare genetic disease, DNA Lig4 Syndrome. The R278H mutation was previously shown to significantly impair the end-ligation function of the protein in the human R278H patient cell line. We previously also demonstrated that mouse cells homozygous for the R278H mutation to show diminished DSB repair capacity. Also paralleling the disease, the Lig4 R278H knock-in mice predispose to T lymphoma and manifest incomplete defects in VDJ, CSR and age-dependent lymphopenia, the latter which implicated potential defects in HSC functions. Our studies of the long-lived HSCs in the R278H knock-in mice reveal that whereas these cells are quiescent and are continually replenished in wild-type mice, we find that these HSCs in both young and old R278H mutant knock-in mice are markedly reduced to 20% of wild-type levels, and appear to undergo increased cycling and g-H2AX induced DNA damage, which may explain their age-dependent lymphopenia. Our findings implicate for the first time a potential physiological role for Lig4 in HSC homeostasis. We also find that introducing rearranged IgH and Igk variable gene exons can bypass the B lymphocyte developmental defects in Lig4 R278H mice, to generate increased numbers of total peripheral B lymphocytes that can undergo robust CSR at near normal levels to specific Ig isotypes, which however still contain high levels of IgH specific DNA breaks and translocations. These latter findings support potential impacts of the R278H mutation in the regulation of the DNA damage signaling cascade, which may also underlie the incomplete CSR defects associated with the R278H disease allele. Thus we suggest Lig4 to not only ligate DNA ends, but also to maintain checkpoint arrest during repair and target irreparably damaged cells to be eliminated, functions we propose are likely fundamental to its role in the maintenance of HSC homeostasis and in CSR. Disclosures: No relevant conflicts of interest to declare.
    Type of Medium: Online Resource
    ISSN: 0006-4971 , 1528-0020
    RVK:
    RVK:
    Language: English
    Publisher: American Society of Hematology
    Publication Date: 2012
    detail.hit.zdb_id: 1468538-3
    detail.hit.zdb_id: 80069-7
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    Online Resource
    Online Resource
    American Society of Hematology ; 2014
    In:  Blood Vol. 124, No. 21 ( 2014-12-06), p. 606-606
    In: Blood, American Society of Hematology, Vol. 124, No. 21 ( 2014-12-06), p. 606-606
    Abstract: Blood cells of all lineages are generated from small pools of long-term hematopoietic stem cells (LT-HSCs) that continually replenish throughout life. LT-HSCs regulate the balanced turnover of all mature blood lineages by switching between self-renewal, differentiation and quiescence, thereby maintaining hematopoietic homeostasis in steady state and in response to injury. In any given cell, some DNA damage may remain despite the action of DNA repair processes, including in LT-HSCs. Over time, HSCs lose their long-term capability to self-renew due to misrepair of DNA breaks and increased accumulation of DNA damage, resulting in loss of regenerative plasticity and immune fitness. The accrual of DNA damage is the principal factor that contributes to functional decline in HSC renewal and in the immune system during ageing. In recent studies, the capacity of aging HSCs to self-renew is shown to be dependent on DNA repair pathways, with non-homologous end-joining (NHEJ) as the principle pathway implicated in DNA repair in quiescent HSCs from ex-vivo cell-based assays. Although NHEJ in particular has been implicated in this process in LT-HSCs, there has so far been very little evidence of this activity in vivo. DNA Ligase IV (Lig4), which catalyzes the end-ligation of broken DNA ends mediated by NHEJ, has no known functions outside of NHEJ. Because a deficiency in Lig4 in mice is embryonic lethal, here we assessed the role of Lig4 in HSC homeostasis by assaying HSC functions in a knockin mouse model of a hypomorphic homozygous R278H mutation in Lig4 that had been identified in the first DNA Lig4 Syndrome patient. The R278H mutation significantly impairs the end-ligation function of the Lig4 protein, and mice homozygous for the R278H mutation (Lig4R/R) showed diminished DSB repair capacity and age-dependent lymphopenia that implicated potential HSC defects. Consistent with a defect in NHEJ, we show the Lig4 R278H mutation severely limited HSC self-renewal. Lig4R/R HSC reconstitutions were skewed towards the myeloid lineage and resulted in severely reduced chimerism, confirming the capacity of HSCs to self-renew requires functional DNA repair. Next, we examined if there is increased DNA damage with/without ionizing irradiation (IR). Lig4R/R LT-HSCs showed an increase in reactive oxygen species (ROS), abnormal cycling and increased apoptosis from accumulated DNA damage in steady state and slow DNA double strand breaks (DSBs) repair kinetics in response to low dose IR because of improper Lig4 function. This led us to check the LT-HSC pool more carefully. It has been shown that the HSC pool is intact and phenotypically increased with age. Strikingly, we found that the HSCs in both young and old Lig4R/R mice are markedly reduced to 20% of wild-type levels. The severe LT-HSC reduction and lethality of disease in Lig4R/Rmice was completely rescued by transplantation with wild type bone marrow. These evidences support the notion of a critical role for Lig4 in maintenance of the LT-HSC pool. In a recent study, it was reported that the steady state pool of murine adult LT-HSCs can be further distinguished into quiescent (~20%) and variably cycling (~80%) populations. Since LT-HSCs in young Lig4R/R mice are maintained in steady state at 20% of WT HSCs, we hypothesized that the reduced pool of LT-HSCs in the Lig4R/R mice is caused by the loss of cycling LT-HSCs that continually replenish blood lineages during aging. To compare these populations, microarray analysis was done on the pool of WT and Lig4R/R LT-HSCs, versus sorted populations of quiescent and variably cycling LT-HSCs. Microarray analysis clearly showed that the Lig4R/RLT-HSCs correlated with the quiescent LT-HSCs, indicating NHEJ regulates the homeostasis of the faster cycling LT-HSC pool. Our study suggest that the slowest cycling LT-HSCs serve to replenish the overall LT-HSC pool and HSC homeostasis is maintained by capacity of faster cycling LT-HSC pool to revert to quiescence in response to stress/injury. Additionally, defective NHEJ depletes the faster cycling LT-HSC pool and underlies early HSC exhaustion in Lig4R/R mice. Our findings demonstrate for the first time a physiological role for Lig4 in the maintenance of HSC homeostasis. Disclosures No relevant conflicts of interest to declare.
    Type of Medium: Online Resource
    ISSN: 0006-4971 , 1528-0020
    RVK:
    RVK:
    Language: English
    Publisher: American Society of Hematology
    Publication Date: 2014
    detail.hit.zdb_id: 1468538-3
    detail.hit.zdb_id: 80069-7
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...